• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BIM
Click for more information
0.00% 8.8¢

BINDI METALS LIMITED - Corporate Spotlight

Market Cap $3.459M  ! watchlist Created with Sketch. Add to my watchlist
Metals & Mining Industrial Metals & Minerals

Bindi Metals Limited is an Australia-based metal mining exploration company. The... Bindi Metals Limited is an Australia-based metal mining exploration company. The Company's projects include Biloela Project, Schryburt Lake Rare Earth and Niobium Project, Lisa Antimony-Gold Project and Mutnica Antimony-Copper Project. The Biloela Project is located within Mt Morgan region, in the New England Orogen. The Project is located 93km southwest of the Port of Gladstone in Central Queensland. The Schryburt Lake Project is located in the prospective Superior Province in Ontario. The tenements are located 120km north of Pickle Lake and only 20km from Newmont’s Musslewhite gold mine. The Lisa Antimony-Gold Project is located in the western portion of Serbia within the Western Tethyan Magmatic Belt. The Lisa Project tenure is in application and covers approximately 30 square kilometers (km2). The Mutnica Antimony-Copper Project is located in the eastern portion of Serbia within the Eastern Tethyan Magmatic Belt. Mutnica Project tenure is granted and comprises 50.5 km2.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

(20min delay)
Last
8.8¢ 		Change
0.000(0.00%) 		Mkt cap ! $3.459M
Open High Low Value Volume
8.8¢ 8.8¢ 8.8¢ $754 8.573K

Buyers (Bids)

No. Vol. Price($)
1 10 9.2¢
 

Sellers (Offers)

Price($) Vol. No.
9.9¢ 20000 1
View Market Depth
Last trade - 09.59am 02/10/2024 (20 minute delay) ?
BIM (ASX) Chart

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one Cobalt Blue has released estimates for what it would take to get its proposed Kwinana refinery off the ground, seeing CapEx of $60M.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
SPC to merge with Original Juice Co and Nature One Dairy The Original Juice Co Ltd has set up a transaction which will see it merge with Aussie icon SPC Global and Singapore-based Nature One Dairy
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.